Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03768492
Study type Interventional
Source NYU Langone Health
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 13, 2019
Completion date April 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05507034 - Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.
Not yet recruiting NCT05603013 - Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) Phase 2
Completed NCT01849133 - Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External Radiotherapy N/A
Completed NCT03002766 - Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast Phase 2
Not yet recruiting NCT04985357 - Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs
Recruiting NCT04790305 - Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer Phase 4
Completed NCT03113825 - Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery Phase 2
Recruiting NCT05461430 - Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)